1. TNT diabetes analysis: Baseline and final LDL cholesterol levels
Atorvastatin 10 mg (n=753)
Atorvastatin 80 mg (n=748)
Mean baseline LDL cholesterol levels (mg/dL) after 8-week open-label treatment
98.0
97.0
Final LDL cholesterol levels (mg/dL) after randomization
98.6
76.7
Shepherd J. American Diabetes Association 2005 Scientific Sessions; June 10-14, 2005; San Diego, CA.

2. TNT diabetes analysis: Efficacy outcomes
Atorvastatin 10 mg (n=753)
Atorvastatin 80 mg (n=748)
Hazard ratio
(95% CI) p
Total major cardiovascular events (%)
17.9
13.8
0.75
( )
0.026
Total major cerebrovascular events (%)
10.0
7.0
0.69
( )
0.037
Shepherd J. American Diabetes Association 2005 Scientific Sessions; June 10-14, 2005; San Diego, CA.